Norges Bank Biogen Inc. Transaction History

Norges Bank

  • $772 Billion
  • Q2 2025

A detailed history of Norges Bank transactions in Biogen Inc. stock. As of the latest transaction made, Norges Bank holds 2,264,177 shares of BIIB stock, worth $343 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,264,177
Holding current value
$343 Million
% of portfolio
0.04%

Shares

52 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$113.38 - $135.49 $257 Million - $307 Million
2,264,177 New
2,264,177 $284 Million
Q4 2024

Feb 12, 2025
BUY
$146.47 - $191.55 $341 Million - $445 Million
2,325,199 New
2,325,199 $356 Million
Q2 2024

Aug 14, 2024
BUY
$190.52 - $236.72 $396 Million - $492 Million
2,078,745 New
2,078,745 $482 Million
Q1 2024

May 14, 2025
BUY
$212.02 - $267.71 $323 Million - $408 Million
1,523,141 New
1,523,141 $328 Million
Q4 2023

Feb 09, 2024
BUY
$222.59 - $267.94 $326 Million - $392 Million
1,463,571 New
1,463,571 $379 Million
Q3 2023

Nov 13, 2024
BUY
$253.3 - $285.89 $387 Million - $437 Million
1,529,096 New
1,529,096 $393 Million
Q3 2023

Nov 13, 2023
SELL
$253.3 - $285.89 $315 Million - $356 Million
-1,244,737 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$275.25 - $318.06 $176 Million - $203 Million
-639,520 Reduced 30.76%
1,439,225 $410 Million
Q2 2023

Aug 14, 2023
SELL
$275.25 - $318.06 $325 Million - $375 Million
-1,179,767 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$256.56 - $292.34 $353 Million - $403 Million
1,377,534 New
1,377,534 $383 Million
Q4 2022

Feb 14, 2023
BUY
$252.44 - $306.72 $330 Million - $401 Million
1,307,702 New
1,307,702 $362 Million
Q3 2022

Nov 13, 2023
BUY
$194.69 - $268.46 $242 Million - $334 Million
1,244,737 New
1,244,737 $332 Million
Q2 2022

Aug 14, 2023
BUY
$187.54 - $223.02 $221 Million - $263 Million
1,179,767 New
1,179,767 $241 Million
Q1 2022

May 12, 2023
BUY
$193.77 - $244.14 $12.3 Million - $15.5 Million
63,351 Added 4.84%
1,371,053 $289 Million
Q1 2022

May 09, 2022
SELL
$193.77 - $244.14 $301 Million - $380 Million
-1,555,205 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$223.92 - $287.77 $348 Million - $448 Million
1,555,205 New
1,555,205 $373 Million
Q3 2021

Nov 14, 2022
BUY
$282.99 - $369.05 $459 Million - $599 Million
1,622,011 New
1,622,011 $459 Million
Q3 2021

Nov 05, 2021
SELL
$282.99 - $369.05 $515 Million - $672 Million
-1,821,151 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$259.0 - $414.71 $472 Million - $755 Million
1,821,151 New
1,821,151 $631 Million
Q2 2021

Aug 10, 2021
SELL
$259.0 - $414.71 $454 Million - $727 Million
-1,752,068 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$242.95 - $284.63 $426 Million - $499 Million
1,752,068 New
1,752,068 $490 Million
Q1 2021

May 07, 2021
SELL
$242.95 - $284.63 $462 Million - $542 Million
-1,903,653 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$236.26 - $355.63 $450 Million - $677 Million
1,903,653 New
1,903,653 $466 Million
Q4 2020

Feb 10, 2021
SELL
$236.26 - $355.63 $476 Million - $717 Million
-2,015,029 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$264.77 - $305.71 $534 Million - $616 Million
2,015,029 New
2,015,029 $572 Million
Q3 2020

Nov 10, 2020
SELL
$264.77 - $305.71 $567 Million - $654 Million
-2,139,660 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$258.66 - $342.55 $553 Million - $733 Million
2,139,660 New
2,139,660 $572 Million
Q2 2020

Aug 07, 2020
SELL
$258.66 - $342.55 $575 Million - $761 Million
-2,221,875 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$268.85 - $341.04 $597 Million - $758 Million
2,221,875 New
2,221,875 $703 Million
Q1 2020

May 08, 2020
SELL
$268.85 - $341.04 $649 Million - $823 Million
-2,413,625 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$220.06 - $304.07 $531 Million - $734 Million
2,413,625 New
2,413,625 $716 Million
Q4 2019

Feb 12, 2020
SELL
$220.06 - $304.07 $496 Million - $686 Million
-2,254,989 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$217.44 - $243.88 $490 Million - $550 Million
2,254,989 New
2,254,989 $525 Million
Q3 2019

Nov 08, 2019
SELL
$217.44 - $243.88 $449 Million - $504 Million
-2,066,244 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$219.29 - $241.72 $453 Million - $499 Million
2,066,244 New
2,066,244 $483 Million
Q2 2019

Aug 09, 2019
SELL
$219.29 - $241.72 $452 Million - $498 Million
-2,060,447 Closed
0 $0
Q1 2019

May 11, 2020
SELL
$216.71 - $338.96 $17.9 Million - $28.1 Million
-82,781 Reduced 3.86%
2,060,447 $487 Million
Q4 2018

Mar 04, 2019
BUY
$278.5 - $352.75 $597 Million - $756 Million
2,143,228 New
2,143,228 $645 Million
Q4 2018

Feb 08, 2019
SELL
$278.5 - $352.75 $603 Million - $763 Million
-2,163,493 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$293.51 - $383.83 $635 Million - $830 Million
2,163,493 New
2,163,493 $764 Million
Q3 2018

Nov 09, 2018
SELL
$293.51 - $383.83 $637 Million - $833 Million
-2,171,447 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$257.52 - $306.91 $559 Million - $666 Million
2,171,447 New
2,171,447 $630 Million
Q2 2018

Jul 23, 2018
SELL
$257.52 - $306.91 $546 Million - $651 Million
-2,120,089 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$260.13 - $367.91 $551 Million - $780 Million
2,120,089 New
2,120,089 $581 Million
Q1 2018

May 09, 2018
SELL
$260.13 - $367.91 $563 Million - $797 Million
-2,165,734 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$307.64 - $344.58 $666 Million - $746 Million
2,165,734 New
2,165,734 $690 Million
Q4 2017

Feb 09, 2018
SELL
$307.64 - $344.58 $621 Million - $696 Million
-2,019,198 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$281.15 - $329.69 $568 Million - $666 Million
2,019,198 New
2,019,198 $632 Million
Q3 2017

Nov 07, 2017
SELL
$281.15 - $329.69 $566 Million - $664 Million
-2,014,477 Closed
0 $0
Q2 2017

Jul 24, 2018
SELL
N/A
-89,357 Reduced 4.25%
2,014,477 $547 Million
Q1 2017

May 11, 2018
BUY
N/A
57,632 Added 2.82%
2,103,834 $575 Million
Q3 2016

Nov 13, 2017
BUY
N/A
2,046,202
2,046,202 $0

Others Institutions Holding BIIB

# of Institutions
1,043
Shares Held
132M
Call Options Held
2.84M
Put Options Held
2.54M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.8B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email